How many clinical trials has Rutgers, The State University of New Jersey sponsored?
ClinicalMetric currently tracks 18 clinical trials sponsored by Rutgers, The State University of New Jersey, of which 18 are actively recruiting participants. These trials cover conditions including Posttraumatic Stress Disorder (PTSD), Substance Use Disorders (SUD), Comorbidity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rutgers, The State University of New Jersey research focus on?
Rutgers, The State University of New Jersey clinical trials span Posttraumatic Stress Disorder (PTSD), Substance Use Disorders (SUD), Comorbidity, Trauma and Stressor Related Disorders, HER2-positive Early-stage Breast Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rutgers, The State University of New Jersey clinical trial?
To participate in a Rutgers, The State University of New Jersey trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rutgers, The State University of New Jersey trials with current recruitment status updated daily.